Syndicate Bio Presented at the 2023 AAADV Workshop

On September 13th, 2023, our CEO, Dr. Abasi Ene-Obong, will deliver a presentation titled 'Genomic Testing in Low- and Middle-Income Countries' at the upcoming 2023 AAADV Workshop. This three-day virtual and interactive workshop features a diverse program, including keynote speakers, plenary sessions, lectures focused on nonprofit advocacy sectors, and moderated discussions.

Recognizing the decades of investment in cancer research that have yielded unprecedented knowledge and intervention opportunities in the cancer trajectory, the event's committee has organized this unique forum. Leaders in clinical and translational cancer research from academia, industry, government, and nonprofit advocacy sectors will come together virtually to expedite the delivery of cancer treatments to patients.

One significant focus of this year's workshop is the potential impact of leveraging the vulnerabilities of pre-malignant cells and conditions to prevent cancer, presenting an additional opportunity to reduce the cancer burden. However, it's important to acknowledge that the development and clinical evaluation of novel cancer prevention strategies remain challenging.

In light of this, the workshop will strategically emphasize both global cancer drug development and the potential and opportunities associated with proven and novel cancer prevention strategies.

To register for this event, please click here: https://aaadv.org